Evaluation of Cardiac Biomarkers in Detection of Cardiomyopathy Induced by Cardiotoxic Chemotherapeutic Agents
Journal Title: Journal of Cancer and Tumor International - Year 2015, Vol 2, Issue 4
Abstract
Background: Doxorubicin is a potent chemotherapeutic drug. The clinical usefulness of doxorubicin has been limited largely by the risk of cardiomyopathy and life-threatening heart failure. Therefore early identification of cardiotoxicity represents a primary goal for cardiologist and oncologist, considering the definition of personalized anticancer therapeutic strategies or intervention. The use of endomyocardial biopsy for detection of myocardial damage and monitoring of cardiac functions is troublesome in clinical practice. Aim: So, evaluation of different cardiac biomarkers was performed to specifically detect myocardial injury and to predict ventricular dysfunction. Methods: Fifty two adult AL patients (mean age 48.9±11.8 years, 25 males) treated with 2–6 cycles of chemotherapy (CT) containing cardiotoxic chemotherapeutic drugs were studied. Cardiac evaluation was performed at baseline, after first and last chemotherapy with cardiotoxic drugs and 6 months after chemotherapy. Results: Mean baseline NT-proBNP (N-terminal pro brain natriuretic peptide) concentration was 109.3±42.7 pg/ml (slightly elevated in 6 patients). After first and last chemotherapy, NT-proBNP elevations to 317.8±147.6 pg/ml and 302.3±123.9 pg/ml were observed, respectively. Six months after CT, mean NT-proBNP concentration was 412.5±184.2 pg/ml (elevated in 32 patients). Changes in NT-proBNP were significant in comparison with the baseline values (p < 0.001). Six months after chemotherapy, four patients with marked NT-proBNP elevations during chemotherapy developed treatment-related cardiomyopathy with symptoms of heart failure. NT-proBNP correlated with systolic and diastolic LV dysfunction on echocardiography (r = 0.638; p < 0.01) and (r = 0.412; p < 0.01). hs-cTnT concentrations were negative (<10 pg/ml) during chemotherapy in all patients. Six months after chemotherapy, delayed hs-cTnT positivity occurred in 6 patients. CK-MB mass remained within the reference range in all patients. Conclusion: The present study suggests that NT-proBNP in blood is better indicator for the detection of doxorubicin induced cardiotoxicity during the treatment and the follow-up than hs-cTnT, cTnI and CK-MB.
Authors and Affiliations
Mrinal Pal, Subinay Datta, Kaushik Ghosh, Ritabrata Mitra, Amit Kumar Pradhan
Keywords
Related Articles
- EP ID EP243000
- DOI 10.9734/JCTI/2015/19169
- Views 108
- Downloads 0
Alkaline Phosphatase and Simple Gray Scale Ultrasonography in Detecting Liver Metastasis in Breast Cancer Patients: A Comparison between Bone Scan Positive and Bone Scan Negative Patients
Alkaline Phosphatase (s-ALP) has been extensively used to monitor the disease and screen the patients for cancer metastasis. Both the baseline s-ALP and changes in s-ALP have been reported as prognostic factors for treat...
Assessment of Survivin and Lactate Dehydrogenase Isoenzyme in Leukemic Egyptian Patients
Accurate diagnosis and proper monitoring of cancer patients remain important obstacles for successful cancer treatment. The search for cancer biomarkers is carried out in order to quickly identify tumor cells and predict...
Primary Breast Lymphoma: A Study of 9 Cases
Aim: Non-Hodgkin's primary lymphoma of the breast is rare. These tumors represent 0.04 to 0.52% of malignant breast pathology, 2.2% of extranodal lymphoma and 0.4% of all non-Hodgkin’s lymphoma. Clinical and radiological...
Analysis of Pelvic Lymph Nodal Metastasis in Operable Cases of Cancer Cervix-A One Year Cohort Study at a Regional Cancer Centre
Objective: To study the incidence of nodal metastasis in early stage operable cases of cancer cervix and to correlate the nodal metastasis with different parameters like stage, degree of differentiation, lympho-vascular...
A Study on Adenexal Masses Diagnosed During Surgery in Pregnancy
Introduction: With improved antenatal care in south India, increase in number of hospital visits by the pregnant women is in turn increasing the detection rate of benign conditions like ovarian cysts during ultrasound. W...